Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

ES-Derived Cells for the Treatment of Alzheimer’s Disease

  • Post author:
  • Post published:June 30, 2025
  • Post category:

Alzheimer’s disease is the most common cause of dementia in the elderly, affecting over 5 million people in the US alone. Boosting immune responses to beta-Amyloid (Aβ) has proven beneficial…

Continue ReadingES-Derived Cells for the Treatment of Alzheimer’s Disease

ES-Derived Cells for the Treatment of Alzheimer’s Disease

  • Post author:
  • Post published:June 30, 2025
  • Post category:

Alzheimer’s disease is the most common cause of dementia in the elderly, affecting over 5 million people in the US alone. Boosting immune responses to beta-Amyloid (Aβ) has proven beneficial…

Continue ReadingES-Derived Cells for the Treatment of Alzheimer’s Disease

Mechanisms of Hematopoietic stem cell Specification and Self-Renewal

  • Post author:
  • Post published:June 30, 2025
  • Post category:

During an individual’s lifetime, blood-forming cells in the bone marrow called hematopoietic stem cells (HSCs) supply all the red and white blood cells needed to sustain life. These blood stem…

Continue ReadingMechanisms of Hematopoietic stem cell Specification and Self-Renewal

Generating pluripotent cell lines from neurons.

  • Post author:
  • Post published:June 30, 2025
  • Post category:

Stem cell research holds great promise for neurological disease. One in three Americans will suffer from diseases of the nervous system ranging from stroke to Alzheimer’s disease to epilepsy. Very…

Continue ReadingGenerating pluripotent cell lines from neurons.

Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy

  • Post author:
  • Post published:June 30, 2025
  • Post category:

Embryonic stem cells (ESC) originating from early stage embryos are able to differentiate into any type of cells in the body. The generation of ESC lines from human embryos (hESC)…

Continue ReadingSkeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy

Molecular mechanisms involved in adult neural stem cell maintenance

  • Post author:
  • Post published:June 30, 2025
  • Post category:

The adult brain contains a pool of stem cells, termed adult neural stem cells, that could be used for regenerative purposes in diseases that affect the nervous system. The goal…

Continue ReadingMolecular mechanisms involved in adult neural stem cell maintenance

A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells

  • Post author:
  • Post published:June 30, 2025
  • Post category:

Cardiovascular diseases account for an estimated $330 billion in health care costs each year, afflict 61.8 million Americans, and will account for more than 1.5 million deaths in the U.S.…

Continue ReadingA Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells

Trithorax and Polycomb methyltransferase complexes in cell fate determination.

  • Post author:
  • Post published:June 30, 2025
  • Post category:

The physiological template of our genome, called chromatin, is composed of DNA wrapped around histone proteins. In the process of development the genome is interpreted in a way that is…

Continue ReadingTrithorax and Polycomb methyltransferase complexes in cell fate determination.

Genetic dissection of mesodermal commitment to the hematopoietic fates.

  • Post author:
  • Post published:June 30, 2025
  • Post category:

Genetic dissection of mesodermal commitment to hematopoietic fates. Hematopoietic cell transplantation is the gold standard for cell-based therapy and is routinely used to treat a wide variety of blood disorders…

Continue ReadingGenetic dissection of mesodermal commitment to the hematopoietic fates.

Oral and Craniofacial Reconstruction Using Mesenchymal Stem Cells

  • Post author:
  • Post published:June 30, 2025
  • Post category:

The overall goal of this proposal is to explore a new stem cell-based treatment for major defects in the orofacial regions resulted from burns, physical injuries, genetic diseases, cancers, infectious…

Continue ReadingOral and Craniofacial Reconstruction Using Mesenchymal Stem Cells
  • Go to the previous page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 37
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us